These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37619661)

  • 1. Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for lung, rectal, prostate and cervical cancers.
    Mackenzie P; Vajdic C; Delaney G; Comans T; Agar M; Gabriel G; Barton M
    Radiother Oncol; 2023 Nov; 188():109862. PubMed ID: 37619661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an age- and comorbidity adjusted- optimal radiotherapy utilisation rate for women with breast cancer.
    Mackenzie P; Vajdic C; Delaney G; Comans T; Agar M; Gabriel G; Barton M
    J Geriatr Oncol; 2022 Jul; 13(6):844-849. PubMed ID: 35514015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting radiotherapy utilisation in geriatric oncology patients in NSW, Australia.
    Mackenzie P; Vajdic C; Delaney G; Gabriel G; Agar M; Comans T; Barton M
    Tech Innov Patient Support Radiat Oncol; 2020 Dec; 16():17-23. PubMed ID: 33385070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy utilisation rates for patients with cancer as a function of age: A systematic review.
    Mackenzie P; Vajdic C; Delaney G; Comans T; Morris L; Agar M; Gabriel G; Barton M
    J Geriatr Oncol; 2023 Apr; 14(3):101387. PubMed ID: 36272958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing a Suitable Radiotherapy Utilisation Benchmark for Older Patients With Head and Neck Cancer.
    Mackenzie P; Vajdic C; Delaney G; Comans T; Agar M; Gabriel G; Barton M
    Clin Oncol (R Coll Radiol); 2024 Oct; 36(10):e381-e387. PubMed ID: 39013658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of radiotherapy underutilisation measured by survival shortfall, years of potential life lost and disability-adjusted life years lost in New South Wales, Australia.
    Batumalai V; Shafiq J; Gabriel G; Hanna TP; Delaney GP; Barton M
    Radiother Oncol; 2018 Nov; 129(2):191-195. PubMed ID: 29983259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provincial variations in radiotherapy utilization as a measure of access: A pan-Canadian study.
    Chan J; Brown E; Dennis K; Milosevic M; Brundage M
    Radiother Oncol; 2022 Feb; 167():122-126. PubMed ID: 34942281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actual Versus Optimal Radiotherapy Utilisation for Metastatic Cancer Patients in the 45 and Up Study Cohort, New South Wales.
    Yap ML; O'Connell DL; Goldsbury DE; Weber MF; Barton MB
    Clin Oncol (R Coll Radiol); 2021 Oct; 33(10):650-660. PubMed ID: 33750600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A decade of investment in radiotherapy in New South Wales: why does the gap between optimal and actual persist?
    Barton MB; Delaney GP
    J Med Imaging Radiat Oncol; 2011 Aug; 55(4):433-41. PubMed ID: 21843180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy utilization in developing countries: An IAEA study.
    Rosenblatt E; Fidarova E; Zubizarreta EH; Barton MB; Jones GW; Mackillop WJ; Cordero L; Yarney J; Lim G; Gan JV; Cernea V; Stojanovic-Rundic S; Strojan P; Kochbati L; Quarneti A
    Radiother Oncol; 2018 Sep; 128(3):400-405. PubMed ID: 29859755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy in rectal cancer: development, adequacy and radiotherapy utilisation rate. A comparative analysis with the most frequent tumour sites.
    García Cabezas S; Palacios Eito A; Martínez Paredes M; Rivin del Campo E
    Clin Transl Oncol; 2011 Feb; 13(2):115-20. PubMed ID: 21324800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated With Radiotherapy Utilisation In New South Wales, Australia: Results From The 45 and Up Study.
    Yap ML; O'Connell DL; Goldsbury D; Weber M; Barton M
    Clin Oncol (R Coll Radiol); 2020 May; 32(5):282-291. PubMed ID: 32007353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving outcomes in non-small cell lung cancer; population analysis of radical radiotherapy.
    Brada M; Ball C; Mitchell S; Forbes H; Ashley S
    Radiother Oncol; 2019 Mar; 132():204-210. PubMed ID: 30392781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer treatment and mortality for Aboriginal people in New South Wales, Australia: results from a population-based record linkage study and medical record audit.
    Gibberd A; Supramaniam R; Dillon A; Armstrong BK; O'Connell DL
    BMC Cancer; 2016 Apr; 16():289. PubMed ID: 27112140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002.
    Vulto AJ; Lemmens VE; Louwman MW; Janssen-Heijnen ML; Poortmans PH; Lybeert ML; Coebergh JW
    Cancer; 2006 Jun; 106(12):2734-42. PubMed ID: 16703598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes to radiotherapy utilisation in Western NSW after the opening of a local service.
    Butler SM
    J Med Radiat Sci; 2017 Dec; 64(4):251-258. PubMed ID: 28160454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does patient age still affect receipt of adjuvant therapy for colorectal cancer in New South Wales, Australia?
    Jorgensen ML; Young JM; Dobbins TA; Solomon MJ
    J Geriatr Oncol; 2014 Jul; 5(3):323-30. PubMed ID: 24656735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy underutilisation and its impact on local control and survival in New South Wales, Australia.
    Merie R; Gabriel G; Shafiq J; Vinod S; Barton M; Delaney GP
    Radiother Oncol; 2019 Dec; 141():41-47. PubMed ID: 31606225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilisation of radiotherapy in lung cancer: A scoping narrative literature review with a focus on the introduction of evidence-based therapeutic approaches in Europe.
    Corral J; Borras JM; Lievens Y
    Clin Transl Radiat Oncol; 2024 Mar; 45():100717. PubMed ID: 38226026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of the optimal utilisation rates of radical prostatectomy, external beam radiotherapy and brachytherapy in the treatment of prostate cancer by a review of clinical practice guidelines.
    Thompson SR; Delaney GP; Jacob S; Shafiq J; Wong K; Hanna TP; Gabriel GS; Barton MB
    Radiother Oncol; 2016 Jan; 118(1):118-21. PubMed ID: 26776443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.